
Personalis PSNL
$ 6.44
-12.09%
Quarterly report 2025-Q3
added 11-04-2025
Personalis EV - Enterprise Value 2011-2026 | PSNL
Annual EV - Enterprise Value Personalis
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 229 M | 143 M | 128 M | 441 M | 1.04 B | 203 M | 148 M | 126 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.04 B | 126 M | 308 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
45.8 B | $ 110.28 | -2.82 % | $ 33.5 B | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Sotera Health Company
SHC
|
7.07 B | $ 13.21 | -2.44 % | $ 3.75 B | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
Biodesix
BDSX
|
142 M | $ 14.31 | -2.02 % | $ 1.86 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 16.41 | -11.3 % | $ 177 M | ||
|
BioNano Genomics
BNGO
|
34.1 M | $ 1.15 | -0.43 % | $ 6.26 M | ||
|
Bioventus
BVS
|
1.01 B | $ 9.03 | -2.48 % | $ 602 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 4.4 | 101.83 % | $ 129 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
28.2 B | $ 62.84 | -4.93 % | $ 24.5 B | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 15.54 | -5.13 % | $ 470 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Guardant Health
GH
|
15.2 B | $ 84.0 | -4.65 % | $ 10.5 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 24.0 | -2.83 % | $ 667 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 158.89 | -3.78 % | $ 7.88 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 195.64 | -1.27 % | $ 21.7 B | ||
|
Organovo Holdings
ONVO
|
-4.05 M | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
10.3 M | - | -16.95 % | $ 1.54 M | ||
|
DarioHealth Corp.
DRIO
|
11 M | $ 8.45 | - | $ 33.7 M | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 102.3 | -0.76 % | $ 8.44 B | ||
|
IDEXX Laboratories
IDXX
|
52.7 B | $ 561.97 | -1.98 % | $ 45.2 B | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
15.3 B | $ 117.62 | -5.45 % | $ 18.7 B | ||
|
PerkinElmer
PKI
|
4 B | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
Interpace Biosciences
IDXG
|
19.7 M | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
Medpace Holdings
MEDP
|
14 B | $ 452.91 | -2.94 % | $ 13.1 B | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 233.1 | -2.91 % | $ 25.4 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.38 | -5.19 % | $ 406 M | ||
|
ENDRA Life Sciences
NDRA
|
864 K | $ 4.26 | -7.19 % | $ 2.29 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 7.35 | -5.28 % | $ 942 M | ||
|
IQVIA Holdings
IQV
|
49.6 B | $ 164.54 | -2.87 % | $ 28.3 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
National Research Corporation
NRC
|
432 M | $ 17.2 | -0.95 % | $ 385 M | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Natera
NTRA
|
5.53 B | $ 184.45 | -5.96 % | $ 18.2 B | ||
|
OPKO Health
OPK
|
1.62 B | $ 1.15 | -1.79 % | $ 798 M |